What are Antibiotic combination therapy drugs?

Antibiotic combination therapy drugs are pharmacologic agents that share a common mechanism (typically targeting Helicobacter pylori DNA and bacterial cell integrity). 5 are currently marketed, with 1 more in clinical development.

What are the marketed Antibiotic combination therapy drugs?

Marketed Antibiotic combination therapy drugs include ADJUNTIVE ANTIBIOTICS, metronidazole based quadriple therapy, Early Dual IV Antibiotic Therapy - MRSA, Tetracycline, Metronidazole, Bismuth subcitrate, Early Dual IV Antibiotic Therapy - MSSA.

Antibiotic combination therapy

5 marketed 1 in Phase 3

This page covers all Antibiotic combination therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Helicobacter pylori DNA and bacterial cell integrity, Bacterial 30S ribosome (tetracycline), bacterial DNA (metronidazole), bacterial cell wall (bismuth).

Targets

Helicobacter pylori DNA and bacterial cell integrity · Bacterial 30S ribosome (tetracycline), bacterial DNA (metronidazole), bacterial cell wall (bismuth)

Marketed (5)

ADJUNTIVE ANTIBIOTICS · University of Valencia · Infectious Disease
Adjunctive antibiotics are antimicrobial agents used in combination with other treatments to enhance therapeutic efficacy and reduce microbial resistance.
metronidazole based quadriple therapy · mohamed bouchoucha · Gastroenterology / Infectious Disease
Metronidazole-based quadruple therapy combines metronidazole with three other agents (typically a proton pump inhibitor, bismuth compound, and tetracycline or clarithromycin) to eradicate Helicobacter pylori through multiple antimicrobial and acid-suppressive mechanisms.
Early Dual IV Antibiotic Therapy - MRSA · West Virginia University · Infectious Disease
Early dual IV antibiotic therapy combines two intravenous antibiotics to simultaneously target methicillin-resistant Staphylococcus aureus (MRSA) through complementary bactericidal mechanisms.
Tetracycline, Metronidazole, Bismuth subcitrate · Mackay Memorial Hospital · Gastroenterology / Infectious Disease
This triple-drug combination eradicates Helicobacter pylori by combining tetracycline's protein synthesis inhibition, metronidazole's DNA damage, and bismuth's bacterial cell wall disruption.
Early Dual IV Antibiotic Therapy - MSSA · West Virginia University · Infectious Disease
Early dual IV antibiotic therapy uses two intravenous antibiotics simultaneously to treat methicillin-sensitive Staphylococcus aureus (MSSA) infections with broader coverage and reduced resistance risk.

Phase 3 pipeline (1)

Concomitant Antibiotic Therapy · Takeda · Infectious Disease
Concomitant antibiotic therapy works by simultaneously administering multiple antibiotics to target bacteria through different mechanisms, reducing resistance and improving treatment efficacy.